Guidance and quality standards awaiting development | Guidance

Showing 251 to 260 of 381

Guidance and quality standards awaiting development
Title	Type
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [ID6720]	Technology appraisal guidance
Pridopidine for treating Huntington's disease [ID6525]	Technology appraisal guidance
Pritelivir (AIC-316) for Herpes simplex virus 2 infection (HSV-2) [12367]	Technology appraisal guidance
Procalcitonin to guide decisions on stopping antibiotics in people with confirmed or highly suspected sepsis	HealthTech guidance
ProKnow cloud-based system for radiotherapy data storage, communication and management	HealthTech guidance
Prostate cancer (hormone relapsed, homologous recombination deficiency, metastatic) – rucaparib (after 1 therapy) [ID6127]	Technology appraisal guidance
Pulsed Field Ablation for Atrial Fibrillation	HealthTech guidance
PXT3003 for treating Charcot-Marie-Tooth disease type 1A in people aged 16 and over [ID1439]	Technology appraisal guidance
Radiofrequency ablation of the basivertebral nerve for chronic low back pain	HealthTech guidance
Radium-223 dichloride with enzalutamide for treating asymptomatic or mildly symptomatic hormone-relapsed metastatic prostate cancer with bone metastases [ID6512]	Technology appraisal guidance